Breathing through barriers: Lived experience, innovation, and the future of Alpha-1 care
Pharmphorum • Fri Jun 13 2025
When a disease runs in your family, you don’t learn about it from textbooks. You learn about it at funerals, in hospital beds, and emergency rooms. My family has lost multiple members to Alpha-1 Antitrypsin Deficiency (Alpha-1), a rare genetic disorder with a deceptively simple origin: a misfolded protein. We didn’t know what it was until my uncle’s misdiagnosis was finally corrected by a well-informed doctor who happened to attend a timely medical conference. That diagnosis saved lives, ours included.
To read more, click here
About AscellaHealth
Healthcare today is more complex than ever—especially when it comes to therapies for people living with rare and chronic conditions. These high-cost, high-impact treatments account for only a small fraction of prescriptions, but they make up the largest and fastest-growing share of total drug spend. As a result, balancing affordability and quality of care remains a significant challenge.
We’re here to change that.
Because at AscellaHealth, we believe that all patients in need should have the ability to access life-changing therapies.
Our Core Beliefs
At AscellaHealth, patients are not just part of the process—they’re why we do what we do. Every solution we build and every partnership we form is designed with the patient in mind.
Patients First, Always.
Balancing Cost and Care.
Better Stakeholder Outcomes.